**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
**Sponsored Content** Advancements in brain tumor treatments are made possible by patients who volunteer to participate in clinical trials.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
